Lallemand Group to Present Yeast and Enzyme Solutions for Plant-Based Foods at Copenhagen Summit

Why It Matters

The showcase positions Lallemand as a key supplier of next‑gen plant‑based ingredients, accelerating product development in a fast‑growing market.

Key Takeaways

• Lallemand showcases Engevita HiPRO Beyond yeast protein for plant foods
• Savor‑Lyfe range adds umami and kokumi flavors to plant products
• Solyve presents enzymes targeting dairy‑alternative processing efficiency
• Presentation highlights microbial solutions for optimized plant‑based dairy
• Bridge2Food summit convenes global plant‑based innovators and researchers

Pulse Analysis

The plant‑based sector is entering a rapid expansion phase, driven by consumer demand for sustainable protein and dairy alternatives. Ingredient manufacturers are under pressure to deliver solutions that mimic the taste, texture, and nutritional profile of animal‑derived foods while keeping costs competitive. Lallemand Group, a global leader in microbial and enzyme technologies, is leveraging its extensive strain library to meet these challenges. By showcasing its portfolio at the Bridge2Food Summit, the company signals a strategic push to capture a larger share of the emerging market.

At the Copenhagen event Lallemand Bio‑Ingredients will unveil Engevita HiPRO Beyond, a high‑protein nutritional yeast designed to boost protein levels in meat‑free formulations without compromising flavor. Complementing the protein boost, the Savor‑Lyfe line offers umami and kokumi yeast‑derived ingredients that deepen mouthfeel and richness, addressing a common consumer complaint about blandness. Solyve, the group’s enzyme arm, will present targeted enzyme blends that improve the functionality of raw materials used in dairy‑alternative production, enhancing texture and shelf‑life while reducing processing time.

The presentation titled ‘Microbial Innovation for Optimized Plant‑Based Dairy’ underscores how precision fermentation and enzyme technology can close the gap between plant and dairy performance. For food manufacturers, access to Lallemand’s microbial cultures and enzyme solutions means faster product cycles and lower formulation risk. As Bridge2Food continues to attract investors and R&D partners, Lallemand’s visibility at the summit could translate into new collaborations, accelerating the rollout of next‑generation plant‑based products across North America and Europe.